Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ADMINISTRATION et al
Case Number:
1:12-cv-00472
Court:
Nature of Suit:
Judge:
Firms
Companies
Government Agencies
Sectors & Industries:
-
July 06, 2012
AstraZeneca Loses Bid To Stretch Seroquel Exclusivity
A Washington federal judge has rejected AstraZeneca PLC's bid to overturn the U.S. Food and Drug Administration's approval of generic versions of its antipsychotic Seroquel on grounds that they violate the drugmaker's exclusivity rights, according to an opinion unsealed Thursday.
-
April 12, 2012
FDA Disputes AstraZeneca's Seroquel Exclusivity Claims
The U.S. Food and Drug Administration said Wednesday that there was no legal basis to AstraZeneca PLC's bid to overturn approval of generic versions of its antipsychotic Seroquel on grounds that they violate the drugmaker's exclusivity rights, and urged a judge to toss AstraZeneca's suit.
-
April 05, 2012
AstraZeneca Claims FDA Skirted Seroquel Exclusivity
AstraZeneca PLC asked a Washington federal judge on Wednesday to vacate U.S. Food and Drug Administration approval of generic versions of its antipsychotic medication Seroquel, arguing the FDA's approval violated the drug company's exclusivity rights.
-
March 29, 2012
Judge Denies AstraZeneca's Seroquel Challenge But Blasts FDA
A federal judge on Wednesday rejected AstraZeneca PLC's attempt to block generic versions of its antipsychotic drug Seroquel from going to market, but also criticized the U.S. Food and Drug Administration for dragging out the court's review of the matter.
-
March 28, 2012
AstraZeneca Sues FDA As Firms Debut Generic Seroquel
AstraZeneca PLC on Tuesday sued the U.S. Food and Drug Administration over the agency's approval this week of a generic version of its antipsychotic medication Seroquel that several pharmaceutical firms announced they would immediately bring to market.